Paul Thibodeau
About Paul Thibodeau
Paul Thibodeau is the Chief Business Officer with nearly two decades of experience in the biopharmaceutical industry, specializing in business development and M&A transactions.
Paul Thibodeau Chief Business Officer
Paul Thibodeau currently serves as the Chief Business Officer. Bringing nearly 20 years of experience in business development within the biopharmaceutical industry, he has taken on numerous leadership roles that have shaped his career trajectory. His extensive background encompasses a range of strategic initiatives and transactions, solidifying his expertise in the field.
Paul Thibodeau's Experience at Novartis
Paul Thibodeau held numerous positions in business development at Novartis. While at the company, he led mergers and acquisitions (M&A) transactions across all therapeutic areas. His work at Novartis allowed him to work on high-impact projects that were crucial to the company's growth in various sectors.
Senior Director of Global Business Development at Teva Cephalon
Paul Thibodeau served as the Senior Director of Global Business Development at Teva Cephalon. In this role, he was responsible for heading all out-licensing and discovery deals for the specialty pipeline. This position enabled him to focus on strategic partnerships and optimize the global business strategies for Teva's specialty offerings.
Business Development Roles at Sanofi Genzyme
At Sanofi Genzyme, Paul Thibodeau held multiple business development positions with increasing responsibilities. He contributed to the growth of the oncology, transplant, and multiple sclerosis franchises. His work involved steering various business strategies and strengthening the company's presence in these therapeutic areas.
Paul Thibodeau's Educational Background
Paul Thibodeau holds a Ph.D. in Cell Biology and Radiobiology from the Université de Sherbrooke in Quebec, Canada. He also completed his B.S. in Biology and Biochemistry at the Université de Moncton, New Brunswick, Canada. Furthering his education, he earned an MBA from the MIT Sloan School of Management, providing him with a strong foundation in both scientific and business disciplines. Additionally, he was a Postdoctoral Research Fellow at the Institut national scientifique et de la recherche médicale (INSERM) in Paris, France.